Sunday, May 08, 2005

America Creates a Virtual Monopoly in Bio-Technologies

According to all observers, it is a given that the United States will carve the lion's share of this strategic market out for itself. A comparative study by EuropaBio, the European Association of Biotech Industries, made public Wednesday, April 13, at the BioVision salon in Lyon, highlighted the lead the Americans have taken in this domain. From a single and even restrictive definition of the reality covered by the term "biotech" - incubators, consultants, certain suppliers of medical material have been excluded from the field - it first of all seems that Europe's backwardness is not due to any deficiency in entrepreneurial spirit: in 2003, 1,975 biotech companies were recorded in the European Union, versus 1,830 in the United States. These companies are located mostly in Great Britain (455) and in Germany (525), but France (225), Sweden (108) and Switzerland (98) occupy significant positions.

posted by ryan griffis  # 2:08 PM

Comments: Post a Comment



Links to this post:

Create a Link



<< Home

Archives

June 2004   July 2004   August 2004   September 2004   October 2004   November 2004   December 2004   January 2005   February 2005   March 2005   April 2005   May 2005   June 2005   July 2005   August 2005   September 2005   October 2005   November 2005   December 2005   January 2006   February 2006   March 2006   April 2006   May 2006   June 2006   July 2006   August 2006   September 2006   October 2006   November 2006   December 2006   January 2007   February 2007   March 2007   April 2007   May 2007   June 2007   July 2007  

syndicate [atom]

preBlog archives

This page is powered by Blogger. Isn't yours?